MedKoo Cat#: 574156 | Name: Rugulotrosin A
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Rugulotrosin A is an antibiotic active against the Gram-positive bacteria E. faecalis, B. cereus, B. subtilis, and S. aureus. Rugulotrosin A is inactive against Gram-negative bacteria.

Chemical Structure

Rugulotrosin A
Rugulotrosin A
CAS#685135-81-3

Theoretical Analysis

MedKoo Cat#: 574156

Name: Rugulotrosin A

CAS#: 685135-81-3

Chemical Formula: C32H30O14

Exact Mass: 638.1636

Molecular Weight: 638.58

Elemental Analysis: C, 60.19; H, 4.74; O, 35.08

Price and Availability

Size Price Availability Quantity
1mg USD 450.00
5mg USD 1,250.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Rugulotrosin A
IUPAC/Chemical Name
(4R,4'R,4aR,4'aR,7R)-rel-2,2',3,3',4,4',9,9'-octahydro-1,1',4,4',8,8'-hexahydroxy-6,6'-dimethyl-9,9'-dioxo-[7,7'-bi-4aH-xanthene]-4a,4'a-dicarboxylic acid dimethyl ester
InChi Key
NCPFIXCVFFDLAF-UHFFFAOYSA-N
InChi Code
InChI=1S/C32H30O14/c1-11-9-15-21(27(39)23-13(33)5-7-17(35)31(23,45-15)29(41)43-3)25(37)19(11)20-12(2)10-16-22(26(20)38)28(40)24-14(34)6-8-18(36)32(24,46-16)30(42)44-4/h9-10,17-18,33-38H,5-8H2,1-4H3
SMILES Code
O=C1C2=C(C=C(C)C(C3=C(O)C(C(C4=C(O)CCC(O)C4(C(OC)=O)O5)=O)=C5C=C3C)=C2O)OC6(C(OC)=O)C(O)CCC(O)=C61
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Rugulotrosin A is active against the Gram-positive bacteria E. faecalis, B. cereus, B. subtilis, and S. aureus with 99% lethal dose (LD99) values of 1.6, 3.1, 5.5, and 200 μg/ml, respectively.
In vitro activity:
Rugulotrosins A and B displayed significant antibacterial activity against Bacillus subtilis, while rugulotrosin A was also strongly active against Enterococcus faecalis and B. cereus. Reference: J Nat Prod. 2004 Apr;67(4):728-30. https://pubmed.ncbi.nlm.nih.gov/15104517/
In vivo activity:
To be determined

Preparing Stock Solutions

The following data is based on the product molecular weight 638.58 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Qin T, Skraba-Joiner SL, Khalil ZG, Johnson RP, Capon RJ, Porco JA Jr. Atropselective syntheses of (-) and (+) rugulotrosin A utilizing point-to-axial chirality transfer. Nat Chem. 2015 Mar;7(3):234-40. doi: 10.1038/nchem.2173. Epub 2015 Feb 2. PMID: 25698333; PMCID: PMC4339264. 2. Stewart M, Capon RJ, White JM, Lacey E, Tennant S, Gill JH, Shaddock MP. Rugulotrosins A and B: Two new antibacterial metabolites from an Australian isolate of a Penicillium sp. J Nat Prod. 2004 Apr;67(4):728-30. doi: 10.1021/np034038b. PMID: 15104517.
In vitro protocol:
1. Qin T, Skraba-Joiner SL, Khalil ZG, Johnson RP, Capon RJ, Porco JA Jr. Atropselective syntheses of (-) and (+) rugulotrosin A utilizing point-to-axial chirality transfer. Nat Chem. 2015 Mar;7(3):234-40. doi: 10.1038/nchem.2173. Epub 2015 Feb 2. PMID: 25698333; PMCID: PMC4339264. 2. Stewart M, Capon RJ, White JM, Lacey E, Tennant S, Gill JH, Shaddock MP. Rugulotrosins A and B: Two new antibacterial metabolites from an Australian isolate of a Penicillium sp. J Nat Prod. 2004 Apr;67(4):728-30. doi: 10.1021/np034038b. PMID: 15104517.
In vivo protocol:
To be determined
1: Chen J, Li Y, Xiao Z, He H, Gao S. Asymmetric Synthesis of Rugulotrosin A. Org Lett. 2020 Feb 21;22(4):1485-1489. doi: 10.1021/acs.orglett.0c00063. Epub 2020 Feb 10. PMID: 32037839. 2: Smyth JE, Butler NM, Keller PA. A twist of nature--the significance of atropisomers in biological systems. Nat Prod Rep. 2015 Nov;32(11):1562-83. doi: 10.1039/c4np00121d. PMID: 26282828. 3: Qin T, Skraba-Joiner SL, Khalil ZG, Johnson RP, Capon RJ, Porco JA Jr. Atropselective syntheses of (-) and (+) rugulotrosin A utilizing point-to-axial chirality transfer. Nat Chem. 2015 Mar;7(3):234-40. doi: 10.1038/nchem.2173. Epub 2015 Feb 2. PMID: 25698333; PMCID: PMC4339264. 4: Stewart M, Capon RJ, White JM, Lacey E, Tennant S, Gill JH, Shaddock MP. Rugulotrosins A and B: Two new antibacterial metabolites from an Australian isolate of a Penicillium sp. J Nat Prod. 2004 Apr;67(4):728-30. doi: 10.1021/np034038b. PMID: 15104517.